Teva study exposes major diagnosis gap in Tardive Dyskinesia
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Access to genomic testing, not therapy cost, is the biggest challenge
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
New facility ‘Amber Wing’ adds 55 beds and strengthens surgical, cardiac, robotic and preventive care infrastructure for women in Mumbai
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
Paves way for CNS cancer test rollout
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Subscribe To Our Newsletter & Stay Updated